Bide Pharmatech Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 252.46 million compared to CNY 177.07 million a year ago. Revenue was CNY 252.46 million compared to CNY 177.07 million a year ago.

Net income was CNY 36.93 million compared to CNY 25.43 million a year ago. Basic earnings per share from continuing operations was CNY 0.4071 compared to CNY 0.3714 a year ago. Diluted earnings per share from continuing operations was CNY 0.4071 compared to CNY 0.3714 a year ago.